<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl3" position="float"><object-id pub-id-type="doi">10.7554/eLife.20707.014</object-id><label>Table 3.</label><caption><p>Time course of pathway enrichment relating to affected and unaffected developmental and functional phenotypes.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20707.014">http://dx.doi.org/10.7554/eLife.20707.014</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="bottom"><p>Phenotype<sup>&#8224;</sup></p></th><th colspan="6" valign="bottom"><p>Development stage*</p></th></tr><tr><th valign="bottom"><p>3 dpf/E1</p></th><th valign="bottom"><p>6 dpf/E2</p></th><th valign="bottom"><p>10 dpf/E3</p></th><th valign="bottom"><p>11 dpf/E4</p></th><th valign="bottom"><p>0 Dph/E5</p></th><th valign="bottom"><p>three Dph/E6</p></th></tr></thead><tbody><tr><td valign="bottom"><p>Cardiovascular</p></td><td valign="bottom"><p>0 (0/8)</p> </td><td valign="bottom"><p>22.4 (11/49)</p> </td><td valign="bottom"><p>5.7 (4/70)</p> </td><td valign="bottom"><p>7.0 (4/57)</p> </td><td valign="bottom"><p>4.7 (2/43)</p> </td><td valign="bottom"><p>2.1 (1/48)</p> </td></tr><tr><td valign="bottom"><p>Craniofacial</p></td><td valign="bottom"><p>0 (0/8)</p> </td><td valign="bottom"><p>12.2 (6/49)</p> </td><td valign="bottom"><p>10 (7/70)</p> </td><td valign="bottom"><p>5.3 (3/57)</p> </td><td valign="bottom"><p>7.0 (3/43)</p> </td><td valign="bottom"><p>2.1 (1/48)</p> </td></tr><tr><td valign="bottom"><p>Liver</p></td><td valign="bottom"><p>12.5 (1/8)</p> </td><td valign="bottom"><p>0 (0/49)</p> </td><td valign="bottom"><p>5.7 (4/70)</p> </td><td valign="bottom"><p>8.8 (5/57)</p> </td><td valign="bottom"><p>0 (0/43)</p> </td><td valign="bottom"><p>0 (0/48)</p> </td></tr><tr><td valign="bottom"><p>Eye</p></td><td valign="bottom"><p>0 (0/8)</p> </td><td valign="bottom"><p>4.1 (2/49)</p> </td><td valign="bottom"><p>20 (14/70)</p> </td><td valign="bottom"><p>48.6 (17/35)</p> </td><td valign="bottom"><p>51.2 (22/43)</p> </td><td valign="bottom"><p>50.0 (24/48)</p> </td></tr><tr><td valign="bottom"><p>Osmoregulation</p></td><td valign="bottom"><p>--</p></td><td valign="bottom"><p>43.3 (13/30)</p> </td><td valign="bottom"><p>29.3 (12/41)</p> </td><td valign="bottom"><p>15.0 (3/20)</p> </td><td valign="bottom"><p>16 (4/25)</p> </td><td valign="bottom"><p>--</p></td></tr><tr><td valign="bottom"><p>Cholesterol</p></td><td valign="bottom"><p>0/30</p></td><td valign="bottom"><p>0 (0/27)</p> </td><td valign="bottom"><p>27.1 (13/48)</p> </td><td valign="bottom"><p>31.3 (10/32)</p> </td><td valign="bottom"><p>25.5 (12/47)</p> </td><td valign="bottom"><p>--</p></td></tr><tr><td valign="bottom"><p>Lipid</p></td><td valign="bottom"><p>0/30</p></td><td valign="bottom"><p>40.7 (11/27)</p> </td><td valign="bottom"><p>35.4 (17/48)</p> </td><td valign="bottom"><p>50.0 (16/32)</p> </td><td valign="bottom"><p>48.9 (23/47)</p> </td><td valign="bottom"><p>--</p></td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>*Percentage of total enriched pathways (absolute values).</p></fn><fn id="tblfn2"><p><sup>&#8224;</sup>Numbers of affected pathways representing Cardiovascular, Craniofacial, Liver and Eye were extracted from the combined Development category in IPA results; numbers of pathways representing osmoregulation/ion transport were extracted from the Molecular Transport category; numbers of pathways affecting Cholesterol/sterol metabolism and other non-cholesterol lipids (Lipid) were extracted from the Lipid Metabolism category.</p></fn></table-wrap-foot></table-wrap>